At the news
? MIXEDIMPACT 6/10 PRESS-RELEASE filed Mar 26, 2026 at 16:30 ET
Inspira Technologies reported minimal revenue of $289,000 in 2025 with a net loss of $13.22 million, reflecting ongoing commercialization challenges. Despite the weak financials, the company secured $49.5 million in binding purchase orders expected to drive revenue in 2026 and raised $4.75 million in a follow-on offering, improving liquidity and Nasdaq compliance. Clinical deployments are expanding, and the company is advancing its HYLA blood sensor platform.
- Reported $289,000 in revenue for 2025, up from $0 in 2024
- Net loss widened to $13.22 million in 2025 from $11.05 million in 2024
- Secured $49.5 million in binding purchase orders, with revenue expected in 2026
- Raised $4.75 million in a registered direct offering post-year-end
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access